Index Investing News
Saturday, May 24, 2025
No Result
View All Result
  • Login
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion
No Result
View All Result
Index Investing News
No Result
View All Result

Texas judge halts FDA approval of abortion pill mifepristone

by Index Investing News
April 8, 2023
in World
Reading Time: 4 mins read
A A
0
Home World
Share on FacebookShare on Twitter

For now, the drug remains available in wake of the separate rulings that were issued just minutes apart by federal judges in Texas and Washington.

AUSTIN, Texas — Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years.

For now, the drug the Food and Drug Administration approved in 2000 appeared to remain at least immediately available in wake of two separate rulings that were issued just minutes apart by federal judges in Texas and Washington.

U.S. District Judge Matthew Kacsmaryk, a Trump appointee, ordered a hold on federal approval of mifepristone in a decision that overruled decades of scientific approval. But that decision came at nearly same time that U.S. District Judge Thomas O. Rice, an Obama appointee, essentially ordered the opposite and directed U.S. authorities not to make any changes that would restrict access to the drug in at least 17 states where Democrats sued in an effort to protect availability.

The extraordinary timing of the competing orders revealed the high stakes surrounding the drug nearly a year after the U.S. Supreme Court overturned Roe v. Wade and curtailed access to abortion across the country.

“FDA is under one order that says you can do nothing and another that says in seven days I’m going to require you to vacate the approval of mifepristone,” said Glenn Cohen of Harvard Law School.

The abortion drug has been widely used in the U.S. since securing FDA approval and there is essentially no precedent for a lone judge overruling the medical decisions of the Food and Drug Administration. Mifepristone is one of two drugs used for medication abortion in the United States, along with misoprostol, which is also used to treat other medical conditions.

Kacsmaryk signed an injunction directing the FDA to stay mifepristone’s approval while a lawsuit challenging the safety and approval of the drug continues. His 67-page order gave the government seven days to appeal.

“Simply put, FDA stonewalled judicial review — until now,” Kacsmaryk wrote.

He didn’t go as far as the plaintiffs wanted by withdrawing or suspending approval of the chemical abortion drug and removing it from the list of approved drugs.

Federal lawyers representing the FDA are expected to swiftly appeal. The White House was reviewing the decision.

Clinics and doctors that prescribe the two-drug combination have said that if mifepristone were pulled from the market, they would switch to using only the second drug, misoprostol. That single-drug approach has a slightly lower rate of effectiveness in ending pregnancies, but it is widely used in countries where mifepristone is illegal or unavailable.

Mifepristone is part of a two-drug regimen that has long been the standard for medication abortion in the U.S. Clinics and doctors that prescribe the combination have said they plan to switch to using only misoprostol. The single-drug approach is slightly less effective at ending pregnancies.

The lawsuit in the Texas case was filed by the Alliance Defending Freedom, which was also involved in the Mississippi case that led to Roe v. Wade being overturned. At the core of the lawsuit is the allegation that the FDA’s initial approval of mifepristone was flawed because it did not adequately review its safety risks.

Courts have long deferred to the FDA on issues of drug safety and effectiveness. But the agency’s authority faces new challenges in a post-Roe legal environment in which abortions are banned or unavailable in 14 states, while 16 states have laws specifically targeting abortion medications.

Democrats and abortion rights groups slammed the ruling out of Texas.

“Abortion is still legal and accessible here in California and we won’t stand by as fundamental freedoms are stripped away,” California Gov. Gavin Newsom said.

Legal experts warned that the ruling could upend decades of precedent, setting the stage for political groups to overturn other FDA approvals of controversial drugs and vaccines.

“This has never happened before in history — it’s a huge deal,” said Greer Donley, a professor specializing in reproductive health care at the University of Pittsburgh Law School. “You have a federal judge who has zero scientific background second guessing every scientific decision that the FDA made.”

Still, because of the contradictory nature of the rulings, Greer and other experts said there would be little immediate impact.

“In the short term, nothing’s going to change,” Greer said. “This is the time to be preparing for the fact that in a week, potentially, mifepristone becomes an unapproved drug in this country.”



Source link

Tags: abortionApprovalFDAHaltsJudgemifepristonePillTexas
ShareTweetShareShare
Previous Post

RCG Ventures Acquires Chicago-Area Retail Asset

Next Post

Johnny Depp’s Big Comeback Movie Gets Its First Trailer!

Related Posts

Paris arrested Telegram founder to meddle in Romanian election — Moscow — RT World Information

Paris arrested Telegram founder to meddle in Romanian election — Moscow — RT World Information

by Index Investing News
May 24, 2025
0

Pavel Durov has stated that French intelligence tried to censor conservatives on the platform throughout election marketing campaign season Russian...

How Canada’s relationship with Israel went from ‘greatest buddy’ to breakdown

How Canada’s relationship with Israel went from ‘greatest buddy’ to breakdown

by Index Investing News
May 24, 2025
0

Warning: This story contains an archival picture of lifeless our bodies.Canada's relationship with Israel has travelled a good distance since...

Why El Salvador President Bukele’s international brokers regulation fuelling democratic issues | World Information

Why El Salvador President Bukele’s international brokers regulation fuelling democratic issues | World Information

by Index Investing News
May 24, 2025
0

Nayib Bukele (Picture: Getty photos) SAN SALVADOR: Human rights organisations, politicians and consultants have sharply criticised a regulation accredited by...

Sea ice information doesn’t disprove warming in Antarctica

Sea ice information doesn’t disprove warming in Antarctica

by Index Investing News
May 24, 2025
0

Social media posts are claiming to disprove the consequences of local weather change in Antarctica by evaluating the quantity of...

Financial Progress is the Fallacious Metric for Our Time — World Points

Financial Progress is the Fallacious Metric for Our Time — World Points

by Index Investing News
May 23, 2025
0

Indonesia’s largest coal mining firm in operation. Even "inexperienced" vitality requires harmful mining for hint minerals. Credit score: Dominik VanyiOpinion...

Next Post
Johnny Depp’s Big Comeback Movie Gets Its First Trailer!

Johnny Depp's Big Comeback Movie Gets Its First Trailer!

Keke Palmer Reveals Her Newborn Gave Her A ‘New Body’: Video – Hollywood Life

Keke Palmer Reveals Her Newborn Gave Her A ‘New Body’: Video – Hollywood Life

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Washington ‘relieved’ UK will cross red line for Kiev – media — RT World News

Washington ‘relieved’ UK will cross red line for Kiev – media — RT World News

May 10, 2023
West Ham verify signing of Gianluca Scamacca

West Ham verify signing of Gianluca Scamacca

July 26, 2022
Soft landing optimism is everywhere. That’s happened before.

Soft landing optimism is everywhere. That’s happened before.

July 31, 2023
The Extent Of Showtime Layoffs Revealed – Deadline

The Extent Of Showtime Layoffs Revealed – Deadline

February 14, 2023
6 Dividend Stocks to Buy in September 2022

6 Dividend Stocks to Buy in September 2022

September 16, 2022
The SC verdict in the Delhi services case is a boost for democracy

The SC verdict in the Delhi services case is a boost for democracy

May 14, 2023
The Store Workspace to Open Coworking Location in Brooklyn

The Store Workspace to Open Coworking Location in Brooklyn

September 25, 2024
Why Co-Shopping for is a Quick However Dangerous Funding Technique

Why Co-Shopping for is a Quick However Dangerous Funding Technique

March 27, 2025
Index Investing News

Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.

  • 1717575246.7
  • Browse the latest news about investing and more
  • Contact us
  • Cookie Privacy Policy
  • Disclaimer
  • DMCA
  • Privacy Policy
  • Terms and Conditions
  • xtw18387b488

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • World
  • Investing
  • Financial
  • Economy
  • Markets
  • Stocks
  • Crypto
  • Property
  • Sport
  • Entertainment
  • Opinion

Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In